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TNF-a Impairs the S-G2/M Cell Cycle Checkpoint
and Cyclobutane Pyrimidine Dimer Repair in
Premalignant Skin Cells: Role of the PI3K–Akt Pathway
Annesofie Faurschou1, Robert Gniadecki1, Damien Calay1,2 and Hans Christian Wulf1
Tumor necrosis factor-a (TNF-a) is induced by UVB radiation and has been implicated in the early stages of skin
carcinogenesis. Here, we show that in normal keratinocytes and the transformed keratinocyte cell lines, HaCaT
and A431, TNF-a stimulates protein kinase B/Akt, which results in activation of the survival complex mTORC1
(mammalian target of rapamycin complex 1) and inhibition of the proapoptotic proteins Bad and FoxO3a. In
UVB-irradiated HaCaT cells (10–20mJ cm2), TNF-a increased the proportion of cycling cells and enhanced the
rate of apoptosis. A significantly higher proportion of UVB-treated HaCaT cells containing unrepaired
cyclobutane pyrimidine dimers (CPDs) escaped the G2/M cell cycle checkpoint in the presence of TNF-a
(9.5±3.3 vs 4.8±2.2%). After treatment with the PI3K inhibitor LY294002, only 1.2±0.7% of CPD-containing
HaCaT cells were actively cycling. TNF-a enhanced apoptosis less potently and did not increase the level of CPD
or stimulate cell cycle progression in normal keratinocytes. Our data suggest that TNF-a overrides the G2/M
checkpoint in premalignant skin cells and allows for some cells containing unrepaired CPD to enter the cell
cycle. The effect of TNF-a seems to be dependent on Akt activation and may constitute a relevant mechanism
enhancing mutagenesis and tumor development.
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INTRODUCTION
Besides its well-known role in inflammation, tumor necrosis
factor-a (TNF-a) is involved in skin carcinogenesis. TNF-a-
and the TNF type 1 receptor knockout mice are protected
against squamous cell carcinoma (Moore et al., 1999; Arnott
et al., 2004). In keratinocytes, TNF-a signals predominantly
via the TNF type 1 receptor and the TRADD–TRAF2–RIP
complex, which causes activation of the atypical protein
kinase C species (PKCz, PKCl/i) and the transcription factor
NF-kB (Anthonsen et al., 2001; Lisby et al., 2006). Whereas
in normal keratinocytes NF-kB signaling seem to protect
against squamous cell carcinoma, deregulated NF-kB activity
in initiated tumor cells confers the antiapoptotic, mitogenic
signal (Dajee et al., 2003; Loercher et al., 2004). In
immortalized, nontumorigenic HaCaT keratinocytes, which
serve as a model of an early, transformed epidermal cancer
cell, TNF-a-induces NF-kB and inhibits anoikis (Ren et al.,
2006). Among many possible mechanisms, NF-kB inhibits
the tumor suppressor gene PTEN (phosphatase and tensin
homologue deleted from chromosome 10) (Kim et al., 2004;
Vasudevan et al., 2004), the most potent repressor of Akt
kinase signaling pathway. Earlier studies indicate that TNF-a
is able to activate Akt (Ozes et al., 1999), but this has not
been seen in all cell types (Janes et al., 2006).
A previous study indicates that TNF-a is able to modulate
the activity of Akt in keratinocytes (Zhang et al., 2001). This
question is relevant, as hyperactivation of Akt is an important
step facilitating tumor development and progression in a
majority of cancers (Altomare and Testa, 2005). Disturbances
in Akt-signaling pathway have recently been demonstrated
in human and murine squamous cell carcinoma (Suzuki
et al., 2003; Segrelles et al., 2006). Mice with hyperactivated
Akt due to keratinocyte-specific PTEN knockout show
hyperplastic and hyperkeratotic epidermis and display
elevated sensitivity to chemical carcinogens and spontaneous
development of papillomas and carcinomas (Suzuki et al.,
2003).
We provide evidence that, in normal keratinocytes and in
the immortalized cell line HaCaT (a model of the precancer-
ous skin lesion (Ren et al., 2006)) and the human squamous
cell carcinoma cell line A431, TNF-a upregulates the activity
of Akt, which results in the activation of its downstream
effector molecular target mTORC1 and inhibition of the
proapoptotic proteins Bad and FoxO3a. We show that TNF-a
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impairs repair of UVB-induced cyclobutane pyrimidine
dimers (CPDs) in HaCaT cells via an Akt-dependent pathway.
RESULTS
TNF-a induces Akt and its downstream effector pathways
(mTORC1, Bad, and FoxO3a) in normal human keratinocytes
and HaCaT cells
Our previous research determined that in cultured murine
and human keratinocytes and in HaCaT cells, TNF-a acti-
vates NF-kB and the transcription of its own gene in the
concentration range of 10–50 ngml1 via the TNF type 1
receptor (Lisby et al., 2006). Treatment with 10 ngml1
recombinant human TNF-a resulted in double phosphory-
lation of Ser-473 and Thr-308 in Akt, reflecting its enzymatic
activation (Figure 1). PI3K inhibitors, LY294002 (Figure 1)
and wortmannin (not shown), blocked the TNF-a-induced
activation of Akt in HaCaT cells. Similarly, LY294002 and
wortmannin have been described to inhibit Akt phosphoryla-
tion in normal human keratinocytes (NHKs) (Wang et al.,
2003). To investigate the physiological consequences of
the TNF-a-induced phosphorylation of Akt, we examined the
functional status of its three main targets: the transcription
factor FoxO3a, the proapoptotic protein Bad, and the survival
complex mTORC1. Akt regulates FoxO3a via complex,
multiple phosphorylations, which cause the deactivation
and translocation of FoxO3a from the nucleus to the
cytoplasm (Biggs III et al., 1999). As shown in Figure 1c,
FoxO3a became rapidly translocated from the nucleus to the
cytoplasm upon treatment with TNF-a. This effect could
be inhibited by LY2944002. Another important down-
stream pathway activated by Akt is the rapamycin-sensitive
mTOR complex 1 (mTORC1)-p70S6K via the tuberous
sclerosis proteins TSC1 and TSC2 and small GTPase Rheb
(Wullschleger et al., 2006). Figure 1a–b documents that the
treatment with TNF-a resulted in phosphorylation of p70S6K
confirming the activation of mTORC1 by this cytokine.
Finally, we also observed that Bad became rapidly phos-
phorylated on Ser112 by TNF-a (Figure 1b), which has
previously been shown to mediate binding to 14-3-3 proteins
and Bad inactivation (Zha et al., 1996). Taken together, these
data provided evidence that TNF-a caused a functional
activation of Akt in keratinocytes.
TNF-a augments Akt phosphorylation in UVB-irradiated
keratinocytes
As the purpose of this study was to investigate how TNF-a
modulates the physiologic response of the keratinocytes
to UV radiation, we determined whether this cytokine
also induced Akt activity in UVB-irradiated HaCaT cells.
In accordance with previous data (Wang et al., 2003), we
showed that UVB induced Akt activity in HaCaT (Figure 2),
A431, and normal keratinocytes (not shown). Relevant doses
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Figure 1. TNF-a induces Akt via the PI3K-sensitive pathways. Cultured cells ((a) NHKs; (b–d) HaCaT) were treated with 10 ngml1 TNF-a for 0–30minutes with
or without the PI3K blocker, LY294002 (20 mM). Protein extracts were analyzed with western blotting using antibodies against phosphorylated Akt (Ser473;
Thr308); total Akt, phosphorylated p70S6K or total and phosphorylated Bad (Ser112) at the indicated times of incubation with TNF-a. (c, d) Inactivation of
FoxO3a by TNF-a in HaCaT cells. Cells were treated with 20 mM LY294002, 10 ngml1 TNF-a or the vehicle (control) for 3 or 24 hours and stained with the mAb
against FoxO3a. Nuclear DNA was labeled with PI/RNase solution. The cells were imaged by (c) confocal microscopy (3 hours) or (d) scanned by LSC (3 hours;
green-FoxO3a, red-PI) to determine integral nuclear FoxO3a fluorescence. Bar¼ 50 mm. The histograms represent n¼5,000 cells.
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of UVB (10–20mJ cm2) caused a moderate increase in Akt
phosphorylation especially on the Thr308 residue, 2.8-fold
increase in phosphorylation of p70S6K (20mJ cm2, 180min-
utes), and deactivation of FoxO3a and Bad in HaCaT cells
(Figure 2). This effect was partially dependent on reactive
oxygen species, as the superoxide scavenger N-acetylcys-
teine (NAC) reduced UVB-dependent Akt phosphorylation
(Figure 2f). a-Tocopherol, a singlet oxygen-quenching agent
did not affect UV-induced Akt/p70 activation, suggesting the
primary involvement of the superoxide (data not shown).
When UVB irradiation was administered to the TNF-a-treated
HaCaT cells, the Akt phosphorylation was more pronounced
on both phosphorylation sites, the effect of which was
reduced by the concomitant administration of NAC (Figure
2b, c and f) but not a-tocopherol (not shown).
Inhibition of PI3K–Akt signaling by LY294002 blocks the
TNF-a-dependent S-phase entry and cell cycle progression
in HaCaT cells
The Akt-signaling pathway confers the antiapoptotic, pro-
survival signals, which in many cell types result in increased
S-phase entry, accelerated cell growth, and resistance to
death signals (Sun et al., 1999). Clonogenic growth of HaCaT
cells cultured in the presence of 10–100 ngml1 TNF-a did
not differ from those of vehicle-treated cells (not shown). This
excludes any major cytotoxic effect or long-term modulation
of cell growth. However, in a 24 hours growth assay, TNF-a
had a small, but significantly growth-enhancing, effect
(Figure 3a). This was further confirmed by the bromodeoxy-
uridine (BrdU) incorporation assay where TNF-a-treated
HaCaT cells showed a higher proportion of S-phase-labeled
cells and shorter S-G1 transition time. As could be expected,
LY294002 retarded cell cycle, causing a G0/G1 arrest at
24 hours (Figure 4a). LY294002 abrogated also the stimula-
tory effects of TNF-a on DNA synthesis (Figure 4a). Thus,
inhibition of the PI3K–Akt axis rendered the cells mitotically
unresponsive to TNF-a, indicating that this signaling pathway
was responsible for the mitogenic effect of this cytokine.
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Figure 2. TNF-a induces Akt in UVB-irradiated cells. Cultured HaCaT cells
were irradiated with 10 or 20mJ cm2 UVB, alone or in combination with
10 ngml1 TNF-a. (a, b) Protein extracts were analyzed with western blotting
as shown in Figure 1. (c, d) Inactivation of FoxO3a by UVB and TNF-a in
HaCaT cells. UVB-irradiated (20mJ cm2) and non-irradiated cells were
treated with 20mM LY294002, 10 ngml1 TNF-a, or the vehicle (control)
for 3 or 24 hours and FoxO3a and DNA were stained as shown in Figure 1.
(c) Average nuclear fluorescence intensity calculated by image analysis of
10–20 cells from confocal images, *Po0.05, t-test in comparison to the
vehicle-treated non-irradiated control. (d) Integral nuclear FoxO3a
fluorescence (n¼5,000 cells) obtained by LSC 3 hours after irradiation as
shown in Figure 1. (e) Cultured cells, HaCaT, were treated with NAC for
45minutes, irradiated with 20mJ cm2 UVB, and/or treated with 10 ngml1
TNF-a for 15minutes. Protein extracts were analyzed with western blotting
as in Figure 1.
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Figure 3. Apoptosis of UVB-irradiated cells in the presence of TNF-a.
(a) Cultured HaCaT cells were irradiated with 0–50mJ cm2 UVB and
cultured in the absence or presence of TNF-a for 24 hours. Cell survival was
determined by a (a) methylene blue assay or (b) clonogenic assay. Inset
graph in (b) shows the same data expressed as the % of control baseline.
n¼ 3, bars: SD. (c) The level of apoptosis was determined by the caspase 3
and 7 activity 4, 24, and 48 hours after irradiation with 0, 10, and 20mJ cm2
UVB for NHKs and HaCaT cells cultured in the presence of TNF-a.
The shown values are means of n¼ 4 experiments with SD.
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TNF-a decreases efficacy of S-G2 cell cycle block in
UVB-irradiated HaCaT cells via a PI3K–Akt-dependent pathway
HaCaT cells have a defective G1 cell cycle checkpoint and
respond to DNA damaging stimuli by arrest in S and G2
phases (Thorn et al., 2001). An intensity of 10–20mJ cm2
UVB caused a dose-dependent decrease in G1 phase cells
and increase in S and G2 cells, both 24 and 48 hours
after irradiation in HaCaT cells and normal keratinocytes
(Figure 4). In comparison to the control cells, TNF-a caused a
marked increase in the proportion of actively cycling, BrdU-
incorporating HaCaT cells in S-phase and decreased the
proportion of G2/M cells after UVB irradiation. Pulse-chase
experiments revealed a more rapid cell-cycle transition of
TNF-a-treated UVB-irradiated HaCaT cells, which could
be reversed by treatment with LY294002 (Figure 4). In
normal keratinocytes, TNF-a did not stimulate DNA synthesis
and cell cycle progression, but acted synergistically with
LY294002, reducing the amount of S phase cells and
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Figure 4. TNF-a stimulates S-phase entry and overrides G2 block in UVB-irradiated cells. (a) Cultured HaCaT cells and (b) NHKs were irradiated with
0–20mJcm2 UVB and cultured for 24–48 hours in the presence of TNF-a, LY294002 or the vehicle (control), as indicated. Cells were pulse-labeled with 10mM
BrdU, fixed and stained with anti-BrdU antibody and PI/RNase, and analyzed by LSC to determine the proportion of cells in different phases of cell cycle.
Proportion of (a, b) HaCaT cells and (c, d) NHKs in G0/G1, S, and G2/M phases in experimental groups calculated from cell-cycle histograms. (e) Cells were
pulse-labeled 30minutes before the termination of the experiment, and DNA histograms with corresponding dot-plots showing BrdU-positive S-phase
cells (gray) were created. x axis on histograms and dot plots represents total (integrated) nuclear PI fluorescence. (f) Cells were pulse-labeled with BrdU
for 30minutes and chased for 2 hours in the presence of colcemid. The number of labeled mitoses was calculated manually from four viewfields in
microscopic epifluorescent images. Means (n¼ 3) with SD. (g) Cells were pulse-labeled with BrdU for 30minutes, chased for 3 hours, fixed, stained and
LSC-scanned as in (c). The number of labeled cells in G1 phase is shown in relation to the total number of G1 cells. Means (n¼3) with SD.
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retarding the cell cycle (Figure 4). In conclusion, TNF-a
seemed to increase the transition through the cell cycle and
attenuated the S-G2 block imposed by UVB in HaCaT cells.
TNF-a enhances survival and proliferation of HaCaT cells
containing unrepaired CPD lesions
As G2 cell cycle checkpoint is relieved when DNA lesions
are repaired, we asked whether the attenuation of G2 cell
cycle block was caused by an enhanced DNA repair of TNF-
a-treated HaCaT cells. As shown in Figure 5a, the TNF-a-
treated cells exhibited a significantly higher level of CPD than
the control cells, both 24 and 48 hours after UVB irradiation.
The cell death assays (methylene blue absorption test and
clonogenic assay) as well as the apoptosis-specific caspase
3/7 activity assay revealed increased apoptotic levels after
TNF-a treatment (Figure 3). NAC did not affect the CPD levels
in the UVB-irradiated and TNF-a-treated or control HaCaT
cells (not shown). In normal keratinocytes, no significantly
elevated levels of CPD was found after irradiation with UVB
and treatment with TNF-a compared to controls. Exposure to
UVB resulted in significantly less apoptotic cells among
normal keratinocytes than HaCaT cells. TNF-a did not
enhance cell death of normal keratinocytes at low UVB dose
(10mJ cm2) but increased apoptosis significantly 48hours
after a high dose of UVB (20mJ cm2) (Figure 3). From these
experiments, we concluded that increased CPD content in
HaCaT cells treated with TNF-a was caused by impaired DNA
repair and not impaired removal of irreversibly damaged cells.
CPD-containing HaCaT cells could be detected by laser
scanning cytometry (LSC) or confocal microscopy after stain-
ing with the specific antibody. The CPDbright cells were distri-
buted in all phases of cell cycle and were more numerous
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Figure 5. Impaired clearance of UVB-induced CPD lesions in TNF-a-treated HaCaT cells. Cells pretreated for 1 hour with 0 or 10 ngml1 TNF-a were irradiated
with the indicated doses of UVB. The dynamics of DNA repair was determined by ELISA specific for CPD for (a) HaCaT cells and (b) NHKs. In (c), HaCaT
cells were doubly labeled with an antibody against CPD and with PI and analysed by LSC. Dot plots represent total nuclear CPD staining plotted against
PI. (d) Double labeling of cells 24 hours after irradiation with 0 (sham) or 10mJ cm2 UVB with the anti-CPD antibody (red) and anti-BrdU (green).
The cells were treated with LY294002, 10 ngml1 TNF-a, or left untreated (control) and pulsed with BrdU 2hours before the termination of the experiment.
The numbers show percentage of BrdUþCPDbright cells (means n¼ 20 with SD). Bar¼ 50 mm.
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in the TNF-a-treated cells, confirming the data gathered by
CPD ELISA (Figure 5). To establish whether the CPDbright cells
were mitotically active, we pulse-labeled the cultures with
BrdU and stained them with the specific antibody against
CPD. In this experiment, we observed that the cells contain-
ing relatively high levels of nuclear CPD were able to enter
S phase and later mitosis (Figure 5c). The proportion of these
cells was significantly higher in the TNF-a-treated cultures
(Po0.003). This effect of TNF-a could be counteracted by
LY294002, which restored the G2 cell cycle block and
caused a general decrease in the number of CPDbright cells.
DISCUSSION
UVB radiation is directly absorbed by DNA and causes form-
ation of mutagenic CPDs. Although most CPDs are removed
by nucleotide excision repair mechanisms, at least two other
protective mechanisms exist in the cells to minimize the risk
of mutations: the cell cycle checkpoints that enable cell cycle
arrest and provide more time for DNA repair, and apoptosis
by which cells containing elevated levels of CPD are
permanently removed. The main finding of this study is that
TNF-a overrides the cell cycle checkpoints and modulates
the apoptotic response to UVB in premalignant skin cells. The
net result is an increased number of mitotically active cells
with unrepaired DNA.
TNF-a is secreted after irradiation with UVB in normal
epidermis and in cultured NHKs and HaCaT cells (Kock et al.,
1990). Earlier studies documented the role of this cytokine as
an accelerator of UVB-induced apoptosis (Schwarz et al.,
1995). Here, we confirm that TNF-a enhances cell death after
UVB. TNF-a also affects the cell cycle. Although long-term
exposure to TNF-a did not increase the cell number in a
2-week clonogenic assay, a short-term treatment increased
acutely the proportion of mitotically active HaCaT cells
(measured by the number of S-phase cells). The increase in
S-phase in TNF-a-treated HaCaT cells was not due to the
G2/M delay, as the proportion of G2/M cells was not different
from the control, and the S-G1 transition time measured as
a proportion of BrdU-labeled cells that reappeared in G1
after 2 hours in a pulse-chase experiment was increased after
TNF-a treatment.
Protein kinase B/Akt is a central kinase involved in the
regulation of cell cycle progression, DNA damage check-
point control and apoptosis. Murine models indicate that in
normal epidermis the Akt-signaling pathway is responsible
for keratinocyte differentiation and survival (Peng et al.,
2003; Calautti et al., 2005). Abnormal activation of Akt is
found is squamous cell carcinomas and sensitizes keratino-
cytes to spontaneous and mutagen-induced transformation
(Suzuki et al., 2003; Segrelles et al., 2006). Overexpression of
Akt stimulates cellular metabolism and enhances mitotic
activity by enhancing S-phase entry (Sun et al., 1999).
We have hypothesized that TNF-a could exert some of the
above-described effects via Akt signaling. Indeed, measure-
ment of Akt phosphorylation status revealed increased
P-Thr308 and P-Ser473 in TNF-a-treated NHK, HaCaT, and
A431 cells synonymous with Akt activation. HaCaT cells
contain high baseline levels of AktPSer473, and Akt activity is
mainly regulated by the second phosphorylation site on
Thr308. The above-described effects of TNF-a on HaCaT cell
apoptosis and accelerated S-phase entry were PI3K depen-
dent, as they could be reversed by LY294002 and were thus
at least partially mediated by Akt. Other signaling pathways
may also be involved. Activation of the mitogen-activated
protein kinase 7/c-Jun-NH2-kinase/activator protein 1 cascade
through the TNF type 1 receptor has recently been shown to
play an important role in TNF-a-mediated cutaneous carcino-
genesis (Zhang et al., 2007). In line with a previous report
(Zhang et al., 2001), we could confirm that the superoxide
scavenger NAC, but not the singlet oxygen quenching
agent a-tocopherol, reduced the TNF- and UVB-induced Akt
activation.
We found that TNF-a had a significant impact on cell
kinetics and DNA repair after UVB irradiation. TNF-a-treated
HaCaT cells showed a less prominent accumulation of cells
in the G2/M phase than the UVB-irradiated controls. This was
associated with a higher proportion of BrdUþ cycling cells
in the TNF-a-treated UVB-irradiated cells, in comparison to
the irradiation alone. After UVB irradiation, a significantly
higher proportion of TNF-a-treated HaCaT cells containing
unrepaired CPD and mitotically active BrdUþ cells. In
normal keratinocytes, TNF-a did not increase the level of
CPD or stimulate cell cycle progression. One of the reasons
for this difference could be the aberration in NF-kB signaling
and p53 signaling in HaCaT cells (Boukamp et al., 1995; Ren
et al., 2006). Thus, the TNF-a-Akt signaling is likely to play
a role at the tumor promotion rather than the initiation stage,
a conclusion that has also been reached by other researchers
(Altomare and Testa, 2005).
Even though TNF-a eliminates the cells with UV-induced
DNA lesions via enhanced apoptosis, this cytokine overrides
the G2/M checkpoint in premalignant skin cells and allows
for some cells containing unrepaired CPD to enter cell cycle.
In other cell types, it has similarly been shown that Akt
activation can overcome cell cycle arrest at G1 and G2/M
checkpoints induced by DNA damage and that cells continue
to divide and accumulate mutations (Henry et al., 2001;
Kandel et al., 2002). Our data suggest that the effect of TNF-a
is dependent on the activation of Akt and may constitute a
relevant mechanism enhancing mutagenesis and tumor
development.
TNF-a treatment led to PI3K-dependent activation of the
survival complex mTORC1-p70S6K and inactivation of the
proapoptotic protein Bad and the transcription factor
FoxO3a, the canonical downstream targets of Akt. The
activated, dephosphorylated FoxO3a is able to block cell
proliferation and induce cell death via bim (Dijkers et al.,
2000) and bcl-xL (Tang et al., 2002). Thus, FoxO transcrip-
tion factors are generally regarded as antiproliferative tumor
suppressors (Hu et al., 2004; Greer and Brunet, 2005). In
the skin, the Akt-dependent deactivation of FoxO3a contri-
butes to squamous cell carcinoma formation in mice, and
probably also in humans (Segrelles et al., 2006). Among
several mechanisms explaining the involvement of FoxO3a
in carcinogenesis, this factor positively affects DNA repair via
p53 and G1/S and G2/M cell cycle arrest (Medema et al.,
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2000; Ramaswamy et al., 2002; Tran et al., 2002; You et al.,
2006). Thus, the TNF-a–Akt–FoxO3a axis may play a role in
the observed G2/M checkpoint suppression.
MATERIALS AND METHODS
Cell culture
NHKs were purchased from CELLnTEC Advanced Cells Systems
(Bern, Switzerland) and cultured in epidermal keratinocyte medium
(CELLnTEC) according to the manufacturer’s instructions. HaCaT
cells (Boukamp et al., 1988) was provided by Dr M.R. Pittelkow
(Mayo Clinic, Rochester, MI) and A431 cells were obtained from
the American Type Culture Collection (Manassas, VA). The cells
were grown in DMEM and MEM, respectively, supplemented with
10% fetal calf serum at 371C in a humidified incubator with
5% CO2. The cell culture reagents were purchased from Gibco BRL
(Life Technologies, Rockville, MD). The cells were tested regularly to
be negative for Mycoplasma.
Reagents and antibodies
LY294002 was from Calbiochem (EMD Biosciences Inc., Darmstadt,
Germany); all other chemicals including recombinant human (rhu)
TNF-a were from Sigma-Aldrich (St Louis, MO). Antibodies against
phosphorylated Akt (Ser473; Thr308), phosphorylated p70S6K, total
p70S6K, phosphorylated Bad (Ser112), and total FoxO3a were
purchased from Cell Signaling (Beverly, MA). Anti-CPD antibodies
were from MBL International (Woburn, MA), the anti-AKT and the
anti-Bad antibodies from BD Transduction Laboratories (BD
Biosciences, San Jose, CA). Anti-BrdU was from Abcam (Cambridge,
UK). Secondary antibodies were Texas red-labeled goat anti-mouse
antibody (Jackson Laboratories, Bar Harbor, ME) or FITC-conjugated
polyclonal porcine anti-rabbit or anti-rat antibody (DakoCytomation,
Glostrup, Denmark) or Alexa 488-conjugated anti-mouse antibody
(Molecular Probes, Invitrogen Corporation, Carlsbad, CA).
UVB irradiation
The cells were irradiated from above in phosphate-buffered saline
(PBS) with doses ranging from 0 to 50mJ cm2 by calibrated Philips
TL12 UVB tubes (Philips, Eindhoven, The Netherlands) with a peak
output around 313nm.
Survival assays
HaCaT cells were seeded in 24-well plates at 100,000 cells per well
and allowed to adhere overnight. After treatment, the cells were
fixed with 4% paraformaldehyde and stained with 0.1% aqueous
methylene blue solution for 15minutes. The dye was extracted with
0.1M HCl and absorbance was measured at 595 nm (Ultraspec III
spectrophotometer, Pharmacia, Uppsala, Sweden). For the clono-
genic growth assay, the cells were seeded into 10 cm Petri dishes
(500 per dish) and allowed to adhere for 24 hours. The next day, the
cells were treated with UVB and incubated with rhu-TNF-a or
LY294002 for 24 hours. After 14 days, the colonies were fixed with
2% paraformaldehyde, stained with 1% crystal violet, and counted
manually if larger than 2mm.
Western blot analysis
The cells were seeded in 6 cm Petri dishes and allowed to grow to
80% confluence. Cells were washed twice in PBS and subsequently
lysed in 200 ml of sample buffer (0.5M Tris-HCl, pH 6.8; 5%
glycerol; 10% SDS; DTT 0.2M).
Bio-Rad Protein Assay kit (Bio-Rad Laboratories, Hercules, CA)
was used to quantify the protein concentration of each sample
according to the manufacturer’s instructions. An equal amount of
total cellular protein (50–100mg) was separated by a 10% SDS-PAGE
at 150V before wet electrotransfer onto a nitrocellulose membrane
(Bio-Rad Laboratories). Membranes were blocked for 1 hour at 41C
with Li-Cor blocking agent (Lincoln, NE) followed by incubation
with either primary mouse or rabbit antibody overnight at 41C.
After the membranes were washed, they were exposed to secondary
antibodies labeled with 700IR dye (anti-mouse) or 800IR dye
(anti-rabbit) (both obtained from Li-Cor) followed by detection and
quantification of the protein bands with the infrared Odyssey
imaging System (Li-Cor).
CPD quantification by ELISA
HaCaT cells were seeded in 6 cm Petri dishes at 300,000 per dish
and cultured for 1 day before UV irradiation. After treatment, the
cells were scraped in 100ml PBS, suspended in 500 ml lysis buffer,
and extracted using Invisorb Spin Cell Mini Kit (Invitek, Berlin,
Germany) as described by the manufacturer. DNA concentration
and purity was measured using a NanoDrop ND-1000 spectro-
photometer (PEQLAB Biotechnologie, Erlangen, Germany).
CPDs were detected by ELISA as recommended by MBL
International Corporation (Woburn, MA). Briefly, DNA samples
were denatured at 1001C for 10minutes, chilled rapidly in an ice
bath for 15minutes, and transferred at a concentration of 1 mgml1
to a flat-bottomed 96-well microtiter plate coated with 0.003%
protamine sulfate. The plates were allowed to dry overnight at 371C.
Next morning, the plates were incubated with 2% fetal calf serum in
PBS to prevent nonspecific antibody binding before incubation with
anti-CPD antibodies. After washing, the plates were incubated with
Biotin-F(ab)2 fragment of anti-mouse IgG (Hþ L) (Invitrogen,
Carlsbad, CA) followed by treatment with peroxidase-streptavidin
(Invitrogen) and incubation with the O-phenylene diamine substrate
solution. The absorbance was determined at 492 nm.
Laser scanning cytometry
For BrdU staining, the cells were cultured on coverslips
and incubated with BrdU for 30minutes before termination of
the experiment. Subsequently, the cells were fixed at 41C in 4%
paraformaldehyde for 20minutes, permeabilized with 1% Triton
X-100 for 10minutes, and then rehydrated with 0.5% PBS/BSA for
15minutes. DNA was denatured with 2M HCl for 30minutes
followed by staining with rat anti-BrdU antibody for 30minutes
at room temperature and 50 mgml1 propidium iodide (PI) with
200mgml1 RNase in PBS for 10minutes at 41C. In some experi-
ments, the cells were treated with 0.1 mgml1 colcemid. Integrated
single-cell fluorescence was measured by LSC (CompuCyte Corp.,
Cambridge, MA) as described previously (Thorn et al., 2001).
The fluorescence was recorded from approximately 5,000 cells
and captured using WinCyte software (CompuCyte). For CPD
staining, the samples were processed identically to the staining
for BrdU, except for the anti-BrdU being replaced with murine
anti-CPD antibody (1:2,500). For FoxO3a staining, the cells were
fixed and permeabilized as above, but the HCl denaturation step
was omitted.
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Confocal microscopy
HaCaT cells were seeded on coverslips, stained as for LSC, and
imaged by an Olympus IX70 confocal laser scanning microscope
(Olympus, FluoView Confocal System). The fluorescence intensity
average was determined for approximately 20 cells in each
experiment using the proprietary Fluoview software.
Quantification of apoptosis
The Caspase-Glo 3/7 (Promega Corporation, Madison, WI) was used
to quantify the UVB-induced cell death after treatment with TNF and
LY according to the manufacturer’s instructions. Luminescence
was measured using a Wallac 1420 Victor3 II microplate-based
luminometer (PerkinElmer, Wellesley, MA).
Statistics
Experiments were conducted in duplicate or triplicate and repeated
2–3 times. Data are presented as means with standard deviation (SD).
Groups were compared using two-sided t-test or ANOVA. Obtaining
a P-value of less than 0.05 was considered significant. The software
used was GraphPad Prism Version 4.03 (GraphPad Software Inc.,
San Diego, CA) or Excel (Microsoft Corp., Redmond, WA).
Institutional approval of the experiments was not necessary.
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